SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending as investors react to recent institutional buying, including a significant boost in Goldman Sachs' position, fueling speculation about future government contracts. The community is actively discussing potential catalysts, such as anticipated rate cuts and the company's expansion into commercial contracts, with some drawing parallels to Palantir's growth trajectory. Many are focused on technical levels, anticipating a breakout above key resistance points and a potential short squeeze.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

LKNCY is trending as community members discuss the potential impact of Starbucks' CEO comments about Luckin's innovation and speed.  Traders are eyeing the $40 mark, with some anticipating a breakout and others expressing frustration over perceived price manipulation.  Overall sentiment seems bullish, fueled by expansion news and speculation around relisting.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IONQ is surging amidst news of regulatory approval for its Oxford Ionics acquisition, sparking discussions about the company's growth potential and future role in the quantum computing landscape. Community members are actively debating the stock's valuation, comparing it to competitors, and anticipating further catalysts such as the Quantum World Congress and potential government contracts. Bullish sentiment appears to be fueled by analyst upgrades and the broader interest in quantum computing, while some express concerns about valuation and profitability.

The vision behind $DAIO's Reward System is simple. Those that hold and buy dips should be rewarded over jeets or buy pressure sellers. In theory if everyone held together the coin would go up right?  Sadly that is not the case but the DAIO feels those that are loyal to a coin shall be rewarded. First use case is $DAIO and the agents that follow. Phase II will unlock it's second use case, the Solana blockchain.

Decentralized AI Organization

Decentralized AI Organization ($DAIO.X) is trending as users highlight its potential as an early-stage AI blockchain play. Community members are drawn to its microcap status, anticipating substantial upside and advocating for strong, early adoption. The token's availability on Phantom is also being noted as a catalyst.

Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. Its product pipeline includes QRX003, QRX004, QRX007, and QRX008. The company was founded by Michael Myers and Denise Carter on March 5, 2018 and is headquartered in Ashburn, VA.

Quoin Pharmaceuticals Ltd - ADR

Quoin Pharmaceuticals is trending amid community speculation around a potential short squeeze and discussions on its low float. Some traders are pointing to positive clinical data and patent filings as potential catalysts. Others caution about the company's history and potential for reverse stock splits.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

PEPE.X is trending as the community speculates on potential price movements and whether it can regain previous highs. Some traders express frustration with volatility, while others see current dips as buying opportunities, signaling divided sentiment. The coin's future performance within the broader meme coin market is a key point of discussion.

RCI Hospitality Holdings, Inc. engages in the provision of live adult entertainment and dining experiences. It operates through the following segments: Nightclubs and Bombshells. The Nightclubs segment includes adult entertainment. The Bombshells segment involves the operation of restaurants and bars. The company was founded by Robert L. Watters in 1983 and is headquartered in Houston, TX.

RCI Hospitality Holdings Inc

RCI Hospitality (RICK) is trending due to an indictment against top executives for alleged tax fraud and bribery, sparking community concern about the company's future and potential impact on liquor licenses; despite the negative news, some investors are seeing this as a buying opportunity, citing the underlying real estate value and strong cash flow, while others question management's capital allocation strategy amid the broader context of recessionary indicators.

Turbo Energy SA provides energy solutions. It engages in the developing, manufacturing and distributing of photovoltaic products. The company was founded on September 18, 2013 and is headquartered in Valencia, Spain.

Turbo Energy S.A. - ADR

Turbo Energy (TURB) is trending due to a recently announced \$53 million contract for energy storage projects, driving significant pre-market gains and high trading volume. Community chatter highlights excitement around the stock's potential for a substantial run, drawing comparisons to other low-float stocks that have experienced similar surges. Traders are actively discussing entry points and strategies to capitalize on the stock's momentum, while also watching for potential pullbacks.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending as the community discusses its potential for further growth, with some eyeing a move towards higher price targets. Bullish sentiment is fueled by news of institutional interest and significant treasury acquisitions. Attention is also focused on various Solana-based tokens and meme coins, with users sharing potential plays.

FGI Industries Ltd. engages in the supply of kitchen and bath products. Its products fall under the following categories: Sanitaryware, Bath Furniture, Shower Systems and Other. The Sanitaryware category offers bath products such as toilets, sinks, pedestals and toilet seats. The Bath Furniture category deals with wood and wood-substitute furniture for bathrooms, including vanities, mirrors, laundry and medicine cabinets, and other storage systems. The Shower Systems category includes a range of shower-related products such as shower walls, shower doors and shower basins. The Others category includes shower door and shower systems products, custom kitchen cabinetry, and other accessory items. The company was founded on May 26, 2021 and is headquartered in East Hanover, NJ.

FGI Industries Ltd

FGI is trending due to a reported 182% gain from specific call options, sparking community interest in its potential for high returns. The community is discussing whether FGI could be the next stock to experience a significant price surge, similar to other recent runners with low floats. Some traders are also debating the sustainability of FGI's momentum, questioning if it's driven by genuine catalysts or just a pump.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SAVA is a reminder not to invest in independent biotech trying to disrupt billion dollar business models. Almost a year since the nonsensical, never-seen-before placebo effect ruined the results and the lives of many. They couldn&#39;t void the patents and steal them. Couldn&#39;t stop the trials. They have locked down people and made violent personal attacks to tarnish reputations. So they did what they had to do to make it match they narrative. Almost a year now. I remember it as if it was yesterday. Ironically, we&#39;ve seen many posts from more experienced investors warning is and who knew exactly it would happen again as it always happens when an independent biotech makes some breakthrough in medical research. I particularly remember a striking post reminding the story of researchers who got mysteriously killed after breakthrough results for a drug. Human nature can be terrifying.

R U Correct

StockTwits Web

StockTwits For Android 

Cassava Sciences Inc

 is a reminder not to invest in independent biotech trying to disrupt billion dollar business models. Almost a year since the nonsensical, never-seen-before placebo effect ruined the results and the lives of many. They couldn't void the patents and steal them. Couldn't stop the trials. They have locked down people and made violent personal attacks to tarnish reputations. So they did what they had to do to make it match they narrative. Almost a year now. I remember it as if it was yesterday. Ironically, we've seen many posts from more experienced investors warning is and who knew exactly it would happen again as it always happens when an independent biotech makes some breakthrough in medical research. I particularly remember a striking post reminding the story of researchers who got mysteriously killed after breakthrough results for a drug. Human nature can be terrifying.

In spite of all these warnings, we&#39;ve decided to stay invested when we should have cut our losses and moved on. It was obviously bound to fail, either from actual bad results -I am still not buying that placebo effect-, either from corruption. We know trial centers are in the pockets of dark, powerful hands. If you&#39;re still invested in this, I wish you best of luck. But I&#39;m convinced they will never allow any drug for any condition to be successful from this company.

In spite of all these warnings, we've decided to stay invested when we should have cut our losses and moved on. It was obviously bound to fail, either from actual bad results -I am still not buying that placebo effect-, either from corruption. We know trial centers are in the pockets of dark, powerful hands. If you're still invested in this, I wish you best of luck. But I'm convinced they will never allow any drug for any condition to be successful from this company.